GleamWall
中文EN

SOLV Solventum Corp

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1964738 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.8%
TTM net income YoY-89.8%
TTM EPS YoY-89.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin54.8%
Operating margin5.6%
Net margin1.9%
FCF margin0.0%
EBITDA margin9.6%

Returns

ROE3.2%
ROA1.1%
ROIC (approx.)4.7%
Asset turnover0.58x

Leverage & solvency

Liabilities / assets66.1%
Debt / equity1.05x
Current ratio1.03x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.99x
Accruals ratio-1.1%
Payout ratio—
Capex / revenue3.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.95B$2.21B$2.01B$2.00B$2.10B$2.16B$2.07B$2.08B
Gross profit$1.06B$1.29B$1.10B$1.03B$1.14B$1.18B$1.11B$1.12B
R&D expense$181.00M$178.00M$189.00M$175.00M$183.00M$189.00M$193.00M$199.00M
SG&A expense$813.00M$927.00M$827.00M$759.00M$780.00M$772.00M$769.00M$784.00M
Operating income$68.00M$181.00M$81.00M$124.00M$1.69B$214.00M$152.00M$136.00M
Pretax income-$11.00M$108.00M$16.00M$58.00M$1.51B$103.00M$38.00M$13.00M
Income tax$1.00M$15.00M$3.00M-$5.00M$248.00M$13.00M-$99.00M-$17.00M
Net income-$12.00M$92.00M$13.00M$63.00M$1.27B$90.00M$137.00M$31.00M
EBITDA$106.00M$217.00M$216.00M$241.00M$1.73B$252.00M$281.00M$286.00M
EPS (basic)-0.070.530.07—7.260.520.79—
EPS (diluted)-0.070.530.07—7.220.510.78—
Weighted avg. shares (diluted)170.80M173.30M175.50M—175.40M175.20M174.80M—
Balance sheet
Cash & equivalents$451.00M$403.00M$561.00M$878.00M$1.64B$492.00M$534.00M$762.00M
Receivables$1.36B$1.31B$1.06B$1.03B$1.02B$1.06B$926.00M$1.04B
Inventory$1.10B$1.04B$1.09B$1.07B$1.05B$962.00M$866.00M$965.00M
Current assets$3.69B$3.74B$3.58B$3.86B$4.41B$3.21B$3.05B$3.25B
PP&E, net$1.59B$1.56B$1.54B$1.33B$1.34B$1.31B$1.20B$1.62B
Goodwill$5.62B$5.63B$5.63B$5.70B$5.26B$5.27B$4.99B$6.38B
Intangibles$2.32B$2.41B$2.50B$2.59B$2.22B$2.30B$2.37B$2.54B
Total assets$14.16B$14.24B$14.10B$14.29B$13.97B$15.07B$14.53B$14.46B
Current liabilities$3.58B$3.66B$3.35B$3.14B$2.94B$2.62B$2.57B$2.70B
Short-term debt$507.00M$506.00M$505.00M$0$0$0$100.00M$200.00M
Long-term debt$4.56B$4.57B$4.58B$5.04B$5.14B$7.82B$7.81B$7.81B
Total debt$5.07B$5.08B$5.08B$5.04B$5.14B$7.82B$7.91B$8.01B
Total liabilities$9.36B$9.44B$9.13B$9.24B$8.99B$11.43B$11.27B$11.50B
Shareholders' equity$4.80B$4.80B$4.97B$5.05B$4.99B$3.65B$3.26B$2.96B
Net debt$4.62B$4.68B$4.52B$4.16B$3.50B$7.32B$7.38B$7.25B
Shares outstanding169.96M170.11M173.53M173.49M173.44M173.39M173.01M172.79M
Cash flow statement
Operating cash flow$177.00M$227.00M-$189.00M$95.00M$76.00M$169.00M$29.00M$219.00M
Capital expenditure$80.00M$83.00M$84.00M$63.00M$97.00M$110.00M$109.00M$127.00M
Free cash flow$97.00M$144.00M-$273.00M$32.00M-$21.00M$59.00M-$80.00M$92.00M
Investing cash flow-$80.00M-$87.00M-$77.00M-$745.00M$3.77B-$110.00M-$114.00M-$127.00M
Financing cash flow-$51.00M-$300.00M-$50.00M-$115.00M-$2.69B-$110.00M-$139.00M-$104.00M
Depreciation & amortization$38.00M$36.00M$135.00M$117.00M$37.00M$38.00M$129.00M$150.00M
Stock-based compensation$42.00M$38.00M$51.00M$37.00M$41.00M$34.00M$49.00M$25.00M
Share buybacks$48.00M$288.00M$67.00M—$0$0$0—

Free plan shows the latest 8 periods; Pro shows all 15 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.